Abstract
The postoperative convalescence period was analyzed for 42 consecutive patients who had cadaveric renal transplantation under therapy with cyclosporin A and steroids. Twenty-two of the patients underwent transplantation for the first time, and the other 20 had retransplantation. None of the recipients has died. With follow-up period of two to eight months, the survival rate of grafts is 96 per cent after first transplantation and 85 per cent after retransplantation. Immunosuppression with a standard regimen was used for all patients at the outset. Early convalescence was highly variable, often necessitating adjustments of cyclosporin A and steroid dosage to accommodate the possibilities of rejection or cyclosporin A nephrotoxicity, or both, simultaneously. Management problems were more frequent and complex in patients undergoing retransplantation. From the results, a classification of convalescence patterns was evolved, with recommendations about how standardized initial therapy should be adjusted if the renal graft does not function promptly or deteriorates later.
MeSH Terms
Adolescent
Adult
Blood Grouping and Crossmatching
Cadaver
Chemical and Drug Induced Liver Injury/etiology
Child
Cyclosporins/administration & dosage,adverse effects
Female
Follow-Up Studies
Graft Survival/drug effects
Humans
Hydrocortisone/administration & dosage
Kidney Transplantation
Male
Middle Aged
Prednisone/administration & dosage
Chemicals
Cyclosporins
Prednisone
Hydrocortisone
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Starzl T E
Hakala T R
Rosenthal J T
Iwatsuki S
Shaw B W
References (15)
15 references, click to expand
-
99mTc-DTPA and 131I-hippuran findings in liver transplant recipients treated with cyclosporin A.
Radiology. 1982 Jan;142(1):199-202
PMID: 7031760
-
Cyclosporin A in cadaveric organ transplantation.
Br Med J (Clin Res Ed). 1981 Mar 21;282(6268):934-6
PMID: 6781658
-
Immunological and pharmacological monitoring in the clinical use of cyclosporin A.
Lancet. 1981 Mar 28;1(8222):686-9
PMID: 6110913
-
Nephrotoxicity of cyclosporin A in liver and kidney transplant patients.
Lancet. 1981 Feb 28;1(8218):470-1
PMID: 6110092
-
The use of cyclosporin A and prednisone in cadaver kidney transplantation.
Surg Gynecol Obstet. 1980 Jul;151(1):17-26
PMID: 6992310
-
Sixteen months experience with cyclosporin-A in human kidney transplantation.
Transplant Proc. 1981 Mar;13(1 Pt 1):365-7
PMID: 7022854
-
100 second renal allografts from a single transplantation institution.
Transplantation. 1979 Jan;27(1):30-4
PMID: 375492
-
Liver transplantation, 1980, with particular reference to cyclosporin-A.
Transplant Proc. 1981 Mar;13(1 Pt 1):281-5
PMID: 7022839
-
Immunopharmacological monitoring of cyclosporin A-treated recipients of cadaveric kidney allografts.
Transplantation. 1982 Jul;34(1):36-45
PMID: 6214878
-
Biological effects of cyclosporin A: a new antilymphocytic agent.
Agents Actions. 1976 Jul;6(4):468-75
PMID: 8969
-
Cyclosporin A to prevent graft-versus-host disease in man after allogeneic bone-marrow transplantation.
Lancet. 1980 Feb 16;1(8164):327-9
PMID: 6101787
-
Cyclosporin A for the oliguric renal transplant patient.
Lancet. 1981 Jan 31;1(8214):276
PMID: 6109926
-
Cyclosporin A and steroid therapy in sixty-six cadaver kidney recipients.
Surg Gynecol Obstet. 1981 Oct;153(4):486-94
PMID: 6269238
-
Cyclosporin A initially as the only immunosuppressant in 34 recipients of cadaveric organs: 32 kidneys, 2 pancreases, and 2 livers.
Lancet. 1979 Nov 17;2(8151):1033-6
PMID: 91781
-
Cyclosporin A in patients receiving renal allografts from cadaver donors.
Lancet. 1978 Dec 23-30;2(8104-5):1323-7
PMID: 82836